Skip to main content
. 2021 Feb 3;6(4):1099–1109. doi: 10.1016/j.ekir.2021.01.034

Figure 1.

Figure 1

Massive ex vivo C5b9 formation along the spectrum of thrombotic microangiopathy (TMA) on the resting endothelium. Control subjects have been tested on the perturbed endothelium (Supplementary Table S4). De novo TMA indicates kidney donor recipients. aHUS, atypical hemolytic uremic syndrome; FHAA, factor H autoantibodies.